Literature DB >> 25931306

Molecular weight and concentration of heparin in hyaluronic acid-based matrices modulates growth factor retention kinetics and stem cell fate.

Amit K Jha1, Anurag Mathur1, Felicia L Svedlund2, Jianqin Ye3, Yerem Yeghiazarians4, Kevin E Healy5.   

Abstract

Growth factors are critical for regulating and inducing various stem cell functions. To study the effects of growth factor delivery kinetics and presentation on stem cell fate, we developed a series of heparin-containing hyaluronic acid (HyA)-based hydrogels with various degrees of growth factor affinity and retention. To characterize this system, we investigated the effect of heparin molecular weight, fractionation, and relative concentration on the loading efficiency and retention kinetics of TGFβ1 as a model growth factor. At equal concentrations, high MW heparin both loaded and retained the greatest amount of TGFβ1, and had the slowest release kinetics, primarily due to the higher affinity with TGFβ1 compared to low MW or unfractionated heparin. Subsequently, we tested the effect of TGFβ1, presented from various heparin-containing matrices, to differentiate a versatile population of Sca-1(+)/CD45(-) cardiac progenitor cells (CPCs) into endothelial cells and form vascular-like networks in vitro. High MW heparin HyA hydrogels stimulated more robust differentiation of CPCs into endothelial cells, which formed vascular-like networks within the hydrogel. This observation was attributed to the ability of high MW heparin HyA hydrogels to sequester endogenously synthesized angiogenic factors within the matrix. These results demonstrate the importance of molecular weight, fractionation, and concentration of heparin on presentation of heparin-binding growth factors and their effect on stem cell differentiation and lineage specification.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac progenitor cell; Growth factor sequestration; HMWH; Hyaluronic acid hydrogel; LMWH; Neovascularization; TGFβ1; UMWH

Mesh:

Substances:

Year:  2015        PMID: 25931306      PMCID: PMC4465536          DOI: 10.1016/j.jconrel.2015.04.034

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  53 in total

1.  Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering.

Authors:  S E Sakiyama; J C Schense; J A Hubbell
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

2.  Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels.

Authors:  A Zieris; K Chwalek; S Prokoph; K R Levental; P B Welzel; U Freudenberg; C Werner
Journal:  J Control Release       Date:  2011-07-06       Impact factor: 9.776

3.  Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants.

Authors:  Robert A Peattie; Erin R Rieke; Erin M Hewett; Robert J Fisher; Xiao Zheng Shu; Glenn D Prestwich
Journal:  Biomaterials       Date:  2005-10-21       Impact factor: 12.479

4.  A microparticle approach to morphogen delivery within pluripotent stem cell aggregates.

Authors:  Andrés M Bratt-Leal; Anh H Nguyen; Katy A Hammersmith; Ankur Singh; Todd C McDevitt
Journal:  Biomaterials       Date:  2013-07-01       Impact factor: 12.479

5.  Development of fibrin derivatives for controlled release of heparin-binding growth factors.

Authors:  S E Sakiyama-Elbert; J A Hubbell
Journal:  J Control Release       Date:  2000-04-03       Impact factor: 9.776

6.  TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro.

Authors:  Marie-José Goumans; Teun P de Boer; Anke M Smits; Linda W van Laake; Patrick van Vliet; Corina H G Metz; Tom H Korfage; K Peter Kats; Ron Hochstenbach; Gerard Pasterkamp; Marianne C Verhaar; Marcel A G van der Heyden; Dominique de Kleijn; Christine L Mummery; Toon A B van Veen; Joost P G Sluijter; Pieter A Doevendans
Journal:  Stem Cell Res       Date:  2008-03-12       Impact factor: 2.020

7.  Controlled release of nerve growth factor enhances sciatic nerve regeneration.

Authors:  Annie C Lee; Vivian M Yu; James B Lowe; Michael J Brenner; Daniel A Hunter; Susan E Mackinnon; Shelly E Sakiyama-Elbert
Journal:  Exp Neurol       Date:  2003-11       Impact factor: 5.330

8.  Stoichiometry of heparin binding to basic fibroblast growth factor.

Authors:  T Arakawa; J Wen; J S Philo
Journal:  Arch Biochem Biophys       Date:  1994-01       Impact factor: 4.013

9.  Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.

Authors:  Michael G Kinsella; Colleen Irvin; Michael A Reidy; Thomas N Wight
Journal:  Atherosclerosis       Date:  2004-07       Impact factor: 5.162

10.  Effects of matrix composition, microstructure, and viscoelasticity on the behaviors of vocal fold fibroblasts cultured in three-dimensional hydrogel networks.

Authors:  Alexandra J E Farran; Sean S Teller; Amit K Jha; Tong Jiao; Rohan A Hule; Rodney J Clifton; Darrin P Pochan; Randall L Duncan; Xinqiao Jia
Journal:  Tissue Eng Part A       Date:  2010-04       Impact factor: 3.845

View more
  20 in total

Review 1.  Methods for Generating Hydrogel Particles for Protein Delivery.

Authors:  Allen L Liu; Andrés J García
Journal:  Ann Biomed Eng       Date:  2016-05-09       Impact factor: 3.934

2.  Controlled Growth Factor Release in 3D-Printed Hydrogels.

Authors:  Pengrui Wang; David Berry; Amy Moran; Frank He; Trevor Tam; Luwen Chen; Shaochen Chen
Journal:  Adv Healthc Mater       Date:  2019-11-07       Impact factor: 9.933

3.  A combined hiPSC-derived endothelial cell and in vitro microfluidic platform for assessing biomaterial-based angiogenesis.

Authors:  Sylvia L Natividad-Diaz; Shane Browne; Amit K Jha; Zhen Ma; Samir Hossainy; Yosuke K Kurokawa; Steven C George; Kevin E Healy
Journal:  Biomaterials       Date:  2018-11-28       Impact factor: 12.479

4.  Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro.

Authors:  Eda I Altiok; Jorge L Santiago-Ortiz; Felicia L Svedlund; Aline Zbinden; Amit K Jha; Deepika Bhatnagar; Peter Loskill; Wesley M Jackson; David V Schaffer; Kevin E Healy
Journal:  Biomaterials       Date:  2016-03-12       Impact factor: 12.479

5.  Matrix metalloproteinase-13 mediated degradation of hyaluronic acid-based matrices orchestrates stem cell engraftment through vascular integration.

Authors:  Amit K Jha; Kevin M Tharp; Shane Browne; Jianqin Ye; Andreas Stahl; Yerem Yeghiazarians; Kevin E Healy
Journal:  Biomaterials       Date:  2016-03-03       Impact factor: 12.479

6.  Heparin Microislands in Microporous Annealed Particle Scaffolds for Accelerated Diabetic Wound Healing.

Authors:  Lauren Pruett; Christian Jenkins; Neharika Singh; Katarina Catallo; Donald Griffin
Journal:  Adv Funct Mater       Date:  2021-06-18       Impact factor: 19.924

Review 7.  Tissue engineering strategies for promoting vascularized bone regeneration.

Authors:  Sarah Almubarak; Hubert Nethercott; Marie Freeberg; Caroline Beaudon; Amit Jha; Wesley Jackson; Ralph Marcucio; Theodore Miclau; Kevin Healy; Chelsea Bahney
Journal:  Bone       Date:  2015-11-19       Impact factor: 4.398

Review 8.  Engineering Biomimetic Materials for Skeletal Muscle Repair and Regeneration.

Authors:  Karina H Nakayama; Mahdis Shayan; Ngan F Huang
Journal:  Adv Healthc Mater       Date:  2019-02-06       Impact factor: 9.933

Review 9.  Growth Factor Immobilization Strategies for Musculoskeletal Disorders.

Authors:  Joseph J Pearson; Johnna S Temenoff
Journal:  Curr Osteoporos Rep       Date:  2022-02-04       Impact factor: 5.096

10.  Chemically modified RNA activated matrices enhance bone regeneration.

Authors:  Satheesh Elangovan; Behnoush Khorsand; Anh-Vu Do; Liu Hong; Alexander Dewerth; Michael Kormann; Ryan D Ross; D Rick Sumner; Chantal Allamargot; Aliasger K Salem
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 11.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.